National research center of Gamaliel and the Ministry of defence proceeded to the final stage of clinical trials of vaccines against coronavirus infection, RIA Novosti reported.
The study began on June 18. Nine participants entered a single component of the vaccine, nine the second. Later, on June 23, the vaccine received an additional 20 volunteers, among them conducting studies of the vaccine in the booster version, they will later introduce a second component of the vaccine.
The first group of July 15, after passing follow-up tests will be discharged, they will return to their duty stations. Now their condition is good, complaints about the health, adverse reactions or adverse events do not exist. The second group of volunteers on 13 July will introduce a second component that should help reinforce the immunity, said the Ministry of defence.
The Ministry stressed that the available data indicated the formation of the volunteers the first and second groups of the immune response to the vaccine from COVID-19.
The trial included both military and civilians. Quantitative and qualitative parameters of the sample of volunteers agreed on the Ministry of health. In total, the trial included 50 volunteers, in addition to civilians, so that soldiers under contract ranging in age from 25 to 50 years, among them five women. In early June, all the volunteers sent two weeks in isolation to avoid the risk of infection by coronavirus.